These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19505257)

  • 21. Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1).
    da Silva J; Hughes AL
    Mol Biol Evol; 1998 Oct; 15(10):1259-68. PubMed ID: 9787432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HIV Replication and PD-1 Expression on CD4+ T Cells.
    Haque M; Lei F; Xiong X; Ren Y; Peng HY; Wang L; Kumar A; Das JK; Song J
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gp120-specific cytotoxic T-lymphocyte function.
    Gupta S; Boppana R; Mishra GC; Saha B; Mitra D
    Immunology; 2008 Aug; 124(4):553-61. PubMed ID: 18298551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of major histocompatibility complex class I/peptide/beta2M tetramers to quantitate CD8(+) cytotoxic T lymphocytes specific for dominant and nondominant viral epitopes in simian-human immunodeficiency virus-infected rhesus monkeys.
    Egan MA; Kuroda MJ; Voss G; Schmitz JE; Charini WA; Lord CI; Forman MA; Letvin NL
    J Virol; 1999 Jul; 73(7):5466-72. PubMed ID: 10364294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes.
    Chen DY; Balamurugan A; Ng HL; Cumberland WG; Yang OO
    Blood; 2012 Jul; 120(1):100-11. PubMed ID: 22613796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
    Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
    J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of promiscuous KIF20A long peptides bearing both CD4+ and CD8+ T-cell epitopes: KIF20A-specific CD4+ T-cell immunity in patients with malignant tumor.
    Tomita Y; Yuno A; Tsukamoto H; Senju S; Kuroda Y; Hirayama M; Irie A; Kawahara K; Yatsuda J; Hamada A; Jono H; Yoshida K; Tsunoda T; Kohrogi H; Yoshitake Y; Nakamura Y; Shinohara M; Nishimura Y
    Clin Cancer Res; 2013 Aug; 19(16):4508-20. PubMed ID: 23714729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral function.
    Foley MH; Forcier T; McAndrew E; Gonzalez M; Chen H; Juelg B; Walker BD; Irvine DJ
    PLoS One; 2014; 9(2):e87873. PubMed ID: 24551068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs.
    Siewe B; Wallace J; Rygielski S; Stapleton JT; Martin J; Deeks SG; Landay A
    PLoS One; 2014; 9(4):e92934. PubMed ID: 24739950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of Antiviral Cytotoxic CD4 T Cell Differentiation.
    Knudson CJ; Férez M; Alves-Peixoto P; Erkes DA; Melo-Silva CR; Tang L; Snyder CM; Sigal LJ
    J Virol; 2021 Sep; 95(19):e0056621. PubMed ID: 34260270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides.
    Sauzet JP; Gras-Masse H; Guillet JG; Gomard E
    Int Immunol; 1996 Apr; 8(4):457-65. PubMed ID: 8671632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
    Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
    J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations.
    Deng K; Pertea M; Rongvaux A; Wang L; Durand CM; Ghiaur G; Lai J; McHugh HL; Hao H; Zhang H; Margolick JB; Gurer C; Murphy AJ; Valenzuela DM; Yancopoulos GD; Deeks SG; Strowig T; Kumar P; Siliciano JD; Salzberg SL; Flavell RA; Shan L; Siliciano RF
    Nature; 2015 Jan; 517(7534):381-5. PubMed ID: 25561180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A; Jin X; Sissons P; Borysiewicz L
    J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production.
    Tomiyama H; Akari H; Adachi A; Takiguchi M
    J Virol; 2002 Aug; 76(15):7535-43. PubMed ID: 12097566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus type 1 infection of antigen-specific CD4 cytotoxic T lymphocytes.
    Robbins PA; Roderiquez GL; Peden KW; Norcross MA
    AIDS Res Hum Retroviruses; 1998 Nov; 14(16):1397-406. PubMed ID: 9824317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lysis of CD4+ lymphocytes by non-HLA-restricted cytotoxic T lymphocytes from HIV-infected individuals.
    Grant MD; Smaill FM; Rosenthal KL
    Clin Exp Immunol; 1993 Sep; 93(3):356-62. PubMed ID: 8103717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential neutralization of human immunodeficiency virus (HIV) replication in autologous CD4 T cells by HIV-specific cytotoxic T lymphocytes.
    Chen H; Piechocka-Trocha A; Miura T; Brockman MA; Julg BD; Baker BM; Rothchild AC; Block BL; Schneidewind A; Koibuchi T; Pereyra F; Allen TM; Walker BD
    J Virol; 2009 Apr; 83(7):3138-49. PubMed ID: 19158248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of a major histocompatibility complex class I-restricted cytotoxic T-lymphocyte response to a highly conserved region of human immunodeficiency virus type 1 (HIV-1) gp120 in seronegative humans immunized with a candidate HIV-1 vaccine.
    Johnson RP; Hammond SA; Trocha A; Siliciano RF; Walker BD
    J Virol; 1994 May; 68(5):3145-53. PubMed ID: 7908700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity.
    Frey BF; Jiang J; Sui Y; Boyd LF; Yu B; Tatsuno G; Billeskov R; Solaymani-Mohammadi S; Berman PW; Margulies DH; Berzofsky JA
    J Immunol; 2018 Mar; 200(5):1853-1864. PubMed ID: 29374075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.